Patents by Inventor Sabine Nakowitsch

Sabine Nakowitsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11510859
    Abstract: A method of increasing the solubility of a water-insoluble or slightly water-soluble hydrophobic organic compound in an aqueous solvent includes adding a saponin component selected from escin, glycyrrhizin, and Quillaya saponaria extract to the aqueous solvent in an amount sufficient to trigger the formation of micelles, wherein in a first step the hydrophobic organic compound is pre-dissolved in an organic solvent, and in a second step the organic solvent comprising the pre-dissolved compound is admixed to the aqueous solvent, whereby at least a part of the insoluble or slightly soluble hydrophobic organic compound gets solubilized and dissolved in the aqueous solvent, yielding an aqueous composition having an increased concentration of said organic compound dissolved therein. Also indicated are pharmaceutical or cosmetic compositions including a water-insoluble or slightly water-soluble organic compound dissolved in an aqueous solvent at substantially increased concentrations.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: November 29, 2022
    Assignee: MARINOMED BIOTECH AG
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Angelika Bodenteich, Martina Morokutti-Kurz, Sabine Nakowitsch, Cornelia Kaintz
  • Patent number: 10220055
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: March 5, 2019
    Assignee: NICOX S.A.
    Inventors: Eva Prieschl-Grassauer, Martina Morokutti-Kurz, Andreas Grassauer, Sabine Nakowitsch, Angelika Bodenteich, Marielle König-Schuster, Christiane Koller, Frederic Pilotaz
  • Publication number: 20190060202
    Abstract: A method of increasing the solubility of a water-insoluble or slightly water-soluble hydrophobic organic compound in an aqueous solvent includes adding a saponin component selected from escin, glycyrrhizin, and Quillaya saponaria extract to the aqueous solvent in an amount sufficient to trigger the formation of micelles, wherein in a first step the hydrophobic organic compound is pre-dissolved in an organic solvent, and in a second step the organic solvent comprising the pre-dissolved compound is admixed to the aqueous solvent, whereby at least a part of the insoluble or slightly soluble hydrophobic organic compound gets solubilized and dissolved in the aqueous solvent, yielding an aqueous composition having an increased concentration of said organic compound dissolved therein. Also indicated are pharmaceutical or cosmetic compositions including a water-insoluble or slightly water-soluble organic compound dissolved in an aqueous solvent at substantially increased concentrations.
    Type: Application
    Filed: July 15, 2016
    Publication date: February 28, 2019
    Applicant: MARINOMED BIOTECH AG
    Inventors: Andreas GRASSAUER, Eva PRIESCHL-GRASSAUER, Angelika BODENTEICH, Martina MOROKUTTI-KURZ, Sabine NAKOWITSCH, Cornelia KAINTZ
  • Publication number: 20160331776
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 17, 2016
    Inventors: Eva PRIESCHL-GRASSAUER, Martina MOROKUTTI-KURZ, Andreas GRASSAUER, Sabine NAKOWITSCH, Angelika BODENTEICH, Marielle KÖNIG-SCHUSTER, Christiane KOLLER, Frederic PILOTAZ
  • Publication number: 20140377308
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 25, 2014
    Inventors: Julia ROMANOVA, Andrej EGOROV, Brigitte KRENN, Markus WOLSCHEK, Sabine NAKOWITSCH
  • Patent number: 8883479
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: November 11, 2014
    Assignee: Baxter Healthcare SA
    Inventors: Brigitte Krenn, Markus Wolschek, Julia Romanova, Andrej Egorov, Sabine Nakowitsch
  • Patent number: 8815252
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: August 26, 2014
    Assignee: Baxter Healthcare SA
    Inventors: Julia Romanova, Andrej Egorov, Brigitte Krenn, Markus Wolschek, Sabine Nakowitsch
  • Publication number: 20110223199
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: November 25, 2009
    Publication date: September 15, 2011
    Applicant: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG
    Inventors: Julia Romanova, Andrej Egorov, Brigitte Krenn, Markus Wolschek, Sabine Nakowitsch
  • Publication number: 20100172934
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: November 25, 2009
    Publication date: July 8, 2010
    Applicant: AVIR Green Hills Biotechnology Research Developmen Trade AG
    Inventors: Brigitte KRENN, Markus WOLSCHEK, Julia ROMANOVA, Andrej EGOROV, Sabine Nakowitsch